Country: Malta
Language: English
Source: Medicines Authority
CIMETIDINE
Delorbis Pharmaceuticals Limited 17 Athinon Str, Ergates Industrial Area, 2643 Ergates, PO Box 28629, 2081 Lefkosia, Cyprus
A02BA01
CIMETIDINE 400 mg
TABLET
CIMETIDINE 400 mg
POM
DRUGS FOR ACID RELATED DISORDERS
Withdrawn
2006-06-01
PATIENT INFORMATION LEAFLET Before you start taking this medicine, please read carefully this patient information leaflet. Keep this patient information leaflet. You may need to read it again. If you have questions or if you do not understand something, ask your doctor or pharmacist. This medicine was given to you and you should not give any of this medicine to anybody else. It might harm them even if they have the same symptoms like yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. TIMET 200 TABLETS TIMET 400 TABLETS The active ingredient is cimetidine. The other ingredients are microcrystalline cellulose, maize starch, magnesium stearate, talc, povidone. Timet 200 are white, concave, round tablets, 10 mm diameter in size. Timet 400 are white, capsule-shaped tablets, 19 x 7 mm, scored on one side. Product License Holder and Manufacturer: Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O.Box 28629, 2081 Lefkosia, Cyprus, European Union. WHAT IS TIMET AND WHAT IS ITS USE Timet is a histamine H 2 -receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. Timet may also have a mucosal protective effect independent of its antisecretory action. Timet is indicated for the: - Treatment of duodenal and benign gastric ulceration. - Treatment of stomal recurrent ulceration. - Treatment of reflux oesophagitis. - Treatment of other conditions where reduction of gastric acid secretion is likely to be beneficial (persistent dyspeptic syndromes, meal related upper abdominal pain). - Management Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT Timet 400 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 400 mg Cimetidine. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets. White, capsule-shaped tablet, 19 x 7 mm, scored on one side. 4. CLINICAL INFORMATION 4.1 THERAPEUTIC INDICATIONS Timet is a histamine H 2 -receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. Timet is indicated in the treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by Timet has been shown to be beneficial: persistent dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastrointestinal haemorrhage from stress ulceration in critically ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson's) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Timet is also recommended in the management of the Zollinger-Ellison syndrome. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Page 1 of 9 The total daily dose by any route should not normally exceed 2.4 g. Dosage should be reduced in patients with impaired renal function. _ADULTS _ _Oral_: For patients with duodenal or benign gastric ulceration, a single daily Read the complete document